GlassScriptPhysician profile
Grace Elizabeth Mason
NPI 1750906715
$2,014.51
in general payments reported to CMS, 2019-2025
17 companies · $271 in 2025
The $271 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $220 · 2022: $398 · 2023: $799 · 2024: $325 · 2025: $271.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,396.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,395.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $201.48 | 2023-2024 | Reblozyl |
| Novocure INC. | $144.79 | 2025 | Optune Lua (Novottf-200t) |
| Beone Medicines USA, INC. | $126.64 | 2025 | Brukinsa |
| Merck Sharp & Dohme LLC | $123.95 | 2024 | Keytruda |
| Beigene USA, INC. | $122.89 | 2023 | Brukinsa |
| Jazz Pharmaceuticals INC. | $121.46 | 2023 | |
| Mirati Therapeutics, INC. | $120.30 | 2023 | Krazati |
| Eusa Pharma (US) LLC | $119.83 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $119.73 | 2023 | Libtayo |
| Btg International INC. | $119.34 | 2024 | |
| Celgene Corporation | $118.39 | 2021 | |
| Seagen INC. | $107.60 | 2023 | Padcev |
| Tersera Therapeutics LLC | $105.21 | 2022 | |
| Glaxosmithkline, LLC. | $101.91 | 2021 | |
| Gilead Sciences, INC. | $95.40 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agios Pharmaceuticals, INC. | $87.57 | 2023 | Pyrukynd |
| Kyowa Kirin, INC. | $78.02 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grace Mason listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.